iPrime is an emerging leader in next-generation IVDs for pathogen detection. We additionally focus on a world-class capability for single-protein interactions, leading to a new generation of immunotherapies and diagnostic agents. Our core mission is to provide these innovative solutions to some of the most pressing issues in healthcare delivery today.
Our single molecule detection platform facilitates real-time identification and quantification of a full spectrum of pathogens. Conventional testing methods, usually focussed on culturing and PCR approaches result in delays in diagnosis and hence treatment, whilst requiring skilled operators and calibrated systems. Our platform enjoys a unique capability to detect individual pathogens within a complex background of other organisms and contaminants.
